Publicaciones en colaboración con investigadoras/es de Universitat de Barcelona (20)

2022

  1. Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation

    American Journal of Transplantation, Vol. 22, Núm. 6, pp. 1671-1682

  2. Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 6, pp. 335-342

  3. Global multi-stakeholder endorsement of the MAFLD definition

    The Lancet Gastroenterology and Hepatology

  4. Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function

    Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24

2021

  1. Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH

    Medicina Clinica, Vol. 156, Núm. 9, pp. 463.e1-463.e30

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

2017

  1. Human immunodeficiency virus–infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study

    Liver Transplantation, Vol. 23, Núm. 5, pp. 645-651

  2. Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance

    Cell Metabolism, Vol. 26, Núm. 1, pp. 212-229.e12

2016

  1. Erratum: Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study (Journal of Hepatology (2015) 62 (92-100))

    Journal of Hepatology

  2. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  3. Liver Retransplantation in Patients with HIV-1 Infection: An International Multicenter Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 2, pp. 679-687

  4. Proteomics and the search for welfare and stress biomarkers in animal production in the one-health context

    Molecular BioSystems, Vol. 12, Núm. 7, pp. 2024-2035

2015

  1. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study

    Journal of Hepatology, Vol. 62, Núm. 1, pp. 92-100

  2. Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer

    Oncotarget, Vol. 6, Núm. 4, pp. 2509-2523

2012

  1. Outcome of HCV/HIV-coinfected liver transplant recipients: A prospective and multicenter cohort study

    American Journal of Transplantation, Vol. 12, Núm. 7, pp. 1866-1876

2010

  1. Recommendations for the management of Sorafenib in patients with hepatocellular carcinoma

    Gastroenterologia y Hepatologia, Vol. 33, Núm. 10, pp. 741-752

1999

  1. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials

    Hepatology, Vol. 29, Núm. 1, pp. 62-67

  2. Prognostic significance of hepatic encephalopathy in patients with cirrhosis

    Journal of Hepatology, Vol. 30, Núm. 5, pp. 890-895

1997

  1. Pulmonary abscess as a complication of transarterial embolization of multinodular hepatocellular carcinoma

    American Journal of Gastroenterology, Vol. 92, Núm. 10, pp. 1942-1943

1996

  1. Diabetes mellitus after liver transplantation: Prevalence and predictive factors

    Journal of Hepatology, Vol. 25, Núm. 1, pp. 64-71